- Clinical Technology
- Adult Immunization
- Hepatology
- Pediatric Immunization
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Infectious Disease
- Obesity Medicine
- Rheumatology
- Nephrology
- Neurology
- Pulmonology
Practical Strategies for Integrating NK Receptor Antagonism for Vasomotor Symptoms Into Primary Care
Panelists discuss how structured monitoring and interdisciplinary collaboration enable safe, effective integration of NK-targeted therapies into primary care.
EP: 1.Impact of Vasomotor Symptoms on Patient Quality of Life
EP: 2.Pathophysiology of Vasomotor Symptoms in Menopause
EP: 3.Unmet Needs in Managing Vasomotor Symptoms in Menopause
EP: 4.NK Receptor Antagonism as Therapeutic Strategy for Vasomotor Symptoms
EP: 5.Managing Vasomotor Symptoms With NK3 Receptor Antagonism
EP: 6.Dual NK3/NK1 Receptor Antagonism for Vasomotor Symptoms
EP: 7.Efficacy and Safety of Elinzanetant in Vasomotor Symptoms in Menopause
EP: 8.Efficacy and Safety of Elinzanetant in Vasomotor Symptoms in Women With Breast Cancer Receiving Endocrine Therapy
EP: 9.Evaluating the Rapid Onset of Vasomotor Symptom Improvement and Safety Profiles of NK Receptor Antagonists
EP: 10.Exploring the Broader Therapeutic Potential of NK1 Receptor Antagonists Beyond Vasomotor Symptoms
EP: 11.Beyond Vasomotor Symptoms: The Potential Role of NK Receptor Antagonism in Mood and Sleep
EP: 12.Positioning NK Receptor Antagonism in the Vasomotor Symptoms Treatment Landscape
EP: 13.Practical Strategies for Integrating NK Receptor Antagonism for Vasomotor Symptoms Into Primary Care
EP: 14.Final Thoughts on Vasomotor Symptoms and NK Receptor Antagonism
As these therapies move into wider use, primary care providers must be prepared to implement them safely. The discussion focuses on practical measures—such as baseline liver function testing, patient counseling, and follow-up scheduling—to ensure optimal use.
Panelists emphasize the importance of interdisciplinary coordination between specialists and primary care clinicians, ensuring consistency in monitoring and education. Standardized protocols will help integrate these therapies into routine practice effectively.
This segment stresses that proactive communication, shared decision-making, and structured monitoring can maximize therapeutic benefit while minimizing risk.
